Publications by authors named "Danny Gibson"

Claim this Profile
M
Modelling Adverse Events in Patients Receiving Chronic Oral Corticosteroids in the UK.
Danny Gibson, Neil Branscombe, Neil Martin, Andrew Menzies-Gow, Priya Jain

Pharmacoecon Open· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal patterns of intermittent oral corticosteroid therapy for asthma in the United Kingdom.
Trung N Tran, Heath Heatley, Jennifer Rowell, Jeffrey Shi Kai Chan, Arnaud Bourdin, Danny Gibson

J Allergy Clin Immunol Glob· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK.
Heide A Stirnadel-Farrant, Sarowar M Golam, Barbara Naisbett-Groet, Danny Gibson, Julia Langham

Rheumatol Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare Resource Use and Costs Associated with Organ Damage in Newly Diagnosed Adults with Systemic Lupus Erythematosus in the UK.
Heide A Stirnadel-Farrant, Sarowar M Golam, Barbara Naisbett-Groet, Danny Gibson, Julia Langham

Rheumatol Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare costs associated with short-acting β-agonists in asthma: observational UK SABINA study.
Darush Attar-Zadeh, Toby Capstick, Deborah Leese, Sofie Arnetorp, Eleni Rapsomaniki, Danny Gibson

BJGP Open· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of tezepelumab in Canada for severe asthma.
Mara Habash, Hannah Guiang, Irvin Mayers, Anna Quinton, Vivian Vuong, Danny Gibson

J Med Econ· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK.
J Mark FitzGerald, Sofie Arnetorp, Caitlin Smare, Danny Gibson, Karen Coulton

Respir Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy vs triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK.
Chris Kiff, Sandrine Ruiz, Nebibe Varol, Danny Gibson, Andrew Davies

Int J Chron Obstruct Pulmon Dis· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population.
Marjan Kerkhof, Trung N Tran, Joan B Soriano, Sarowar Golam, Danny Gibson

Thorax· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What can we learn from Italian lessons?
Danny Gibson

Health Estate· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis